PRKAG2 and cardiomyopathy: A next-generation sequencing genetic analysis with a cardiomyopathy dedicated gene panel (INVITAE laboratory, United States) was performed in all three family members, identifying a missense pathogenic variant (c.905G>A, Arg302Gln, heterozygous) in the PRKAG2 gene.